Osteogenic sarcoma (osteosarcoma): results of therapy.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001859:Bone Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005266:Femoral Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D005500:Follow-Up Studies; D005624:Frontal Bone; D006801:Humans; D006811:Humerus; D007085:Ilium; D008297:Male; D008339:Mandibular Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D008441:Maxillary Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D009362:Neoplasm Metastasis; D012516:Osteosarcoma / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D011882:Radiotherapy, High-Energy; D012447:Sacrum; D013100:Sphenoid Bone; D013977:Tibia; D014750:Vincristine / Q000627:therapeutic use
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D008558:Melphalan